Location History:
- Nagoya, JP (2010 - 2015)
- Aichi, JP (2014 - 2015)
Company Filing History:
2 out of 371 
2 out of 10 
2 out of 16,115 
Years Active: 2010-2015
Title: Innovations by Takashi Takahashi
Introduction
Takashi Takahashi is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of cancer research, holding a total of five patents. His work focuses on developing methods and compounds that target cancer cell mechanisms, aiming to improve treatment outcomes.
Latest Patents
One of his latest patents is a method for suppressing receptor tyrosine kinase-mediated pro-survival signaling in cancer cells. This invention provides a screening method for compounds capable of targeting ROR1, which is crucial for suppressing cancer cell survival mechanisms. It has been discovered that inhibiting ROR1 can effectively suppress the growth of cancer cell lines that have developed resistance to receptor tyrosine kinase inhibitors such as EGFR and MET. Another notable patent is for an anti-human CLCP1 antibody and its various applications. This invention includes novel antibodies that recognize the extracellular domain of the human CLCP1 antigen, along with methods for producing these antibodies and their use in diagnosing and treating CLCP1-expressing cancers.
Career Highlights
Takashi has worked with esteemed institutions such as Nagoya University and Aichi Prefecture. His research has significantly advanced the understanding of cancer biology and therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Tomoya Yamaguchi and Shuta Tomita, contributing to various research projects and innovations in cancer treatment.
Conclusion
Takashi Takahashi's innovative work in cancer research exemplifies the impact of targeted therapies in improving patient outcomes. His patents reflect a commitment to advancing medical science and providing new hope for cancer patients.